Cargando…
Correction: Dexmedetomidine attenuates lipopolysaccharide-induced acute liver injury in rats by inhibiting caveolin-1 downstream signaling pathway
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173524/ http://dx.doi.org/10.1042/BSR-20204279_COR |
Ejemplares similares
-
Dexmedetomidine attenuates lipopolysaccharide-induced acute liver injury in rats by inhibiting caveolin-1 downstream signaling pathway
por: Tong, Fei, et al.
Publicado: (2021) -
Correction to: Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation
por: Huang, Yaru, et al.
Publicado: (2021) -
Correction: Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling
Publicado: (2021) -
Author Correction: Fc-apelin fusion protein attenuates lipopolysaccharide-induced liver injury in mice
por: Zhou, Huifen, et al.
Publicado: (2018) -
Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress, mitochondrial dysfunction and apoptosis in rats
por: Fu, Chunlai, et al.
Publicado: (2017)